Core Laboratories (CLB) Current Assets (2022 - 2026)

Core Laboratories' Current Assets history runs 5 years deep, the most recent figure standing at $214.4 million for Q1 2026.

• On a quarterly basis, Current Assets fell 6.29% year-over-year to $214.4 million in Q1 2026; TTM through Mar 2026 was $214.4 million, a 6.29% decrease from a year earlier, with the FY2025 full-year figure at $214.7 million, down 3.01% from the prior year.
• Current Assets was little changed at $214.4 million in Q1 2026 per CLB's latest filing, from $214.7 million in the prior quarter.
• Across five years, Current Assets topped out at $237.7 million in Q2 2025 and bottomed at $211.7 million in Q4 2022.
• The 5-year median for Current Assets is $228.5 million (2023), against an average of $226.2 million.
• Across the five-year window, Current Assets increased 5.4% in 2023 and dropped 6.29% in 2026, its largest moves.
• Year by year, Current Assets stood at $211.7 million in 2022, then advanced by 5.4% to $223.1 million in 2023, then decreased by 0.81% to $221.3 million in 2024, then fell by 3.01% to $214.7 million in 2025, then fell by 0.14% to $214.4 million in 2026.
• Per Business Quant, the three latest CLB Current Assets figures stand at $214.4 million (Q1 2026), $214.7 million (Q4 2025), and $226.9 million (Q3 2025).